IL17A and carcinoma: The aim of this pilot study was to evaluate the expression of the proinflammatory cytokine IL-17 along the Barrett's metaplasia-dysplasia-carcinoma sequence by establishing the expression levels of IL-17 in columnar epithelium, intestinal metaplastic cells, and dysplastic/glandular neoplastic cells.